Ahn-Gook Pharmaceutical

안국약품 · 001540

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$107.3M (₩148B)

Overview

Ahn-Gook Pharmaceutical makes prescription medicines, including treatments for coughs and cardiovascular conditions, as well as health supplements such as an eye-health product called Tovicom, supplying patients and healthcare providers across South Korea.

It is listed on KOSDAQ, South Korea's small-cap and technology board. Alongside its branded products, the company operates a contract manufacturing business, producing medicines for other pharmaceutical companies from its factory in Hwaseong.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$222.4M

▲ +13.2% YoY

Operating profit · FY2025

US$7.1M

▲ +46.6% YoY

Net income · FY2025

US$5.3M

▼ −55.2% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$169.3M(₩233.7B)	US$196.5M(₩271.1B)	US$222.4M(₩306.9B)
Operating profit	US$3.7M(₩5.1B)	US$4.9M(₩6.7B)	US$7.1M(₩9.8B)
Net income	US$723.4K(₩998.3M)	US$11.8M(₩16.3B)	US$5.3M(₩7.3B)

Revenue

FY2023US$169.3M
FY2024US$196.5M
FY2025US$222.4M

Operating profit

FY2023US$3.7M
FY2024US$4.9M
FY2025US$7.1M

Net income

FY2023US$723.4K
FY2024US$11.8M
FY2025US$5.3M

Key ratios (FY2025)

ROE

4.4%

Debt/Eq

87.0%

Op. margin

3.2%

Net margin

2.4%

Rev. YoY

▲ +13.2%

Why it matters

The company runs its own online distribution channel, 'Awonder', and is expanding into healthcare and beauty categories beyond its core pharmaceutical lines.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?